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Abstract
We aimed to analyze the effects of percutaneous transluminal angioplasty (PTA)
of the superficial femoral artery (SFA) on arterial pulse waves (PWs). Al-
together 24 subjects i.e. 48 lower limbs were examined including 26 treated
lower limbs having abnormal ankle-to-brachial pressure index (ABI) (ABI< 0.9
or ABI> 1.3) and 22 non-treated lower limbs. The measurements were con-
ducted in pre-, peri- and post-treatment phases as well as in follow-up visit
after 1 month. Both ABI and toe pressures measured by standard equipment
were used as reference values. PW-derived parameters include ratios of different
peaks of the PW and time differences between them as well as aging index. Both
treated and non-treated limbs were compared in pre- and post-treatment as well
as follow-up visit conditions. The results were evaluated in terms of statistical
tests, Bland-Altman-plots, free-marginal multirater κ-analysis and multiple lin-
ear regression analysis. PTA was found to cause small changes to the studied
PW-derived parameters of the treated limb which were observed immediately
after the treatment, but the changes were more pronounced in the follow-up
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visit. In addition, we observed that the endovascular instrumentation itself
does not cause significant changes to the PW-derived parameters. The results
show that PW-analysis could be a useful tool for monitoring the treatment-effect
of the PTA. However, because the pre-treatment differences of the treated and
non-treated limb were small, further studies with subjects having no arterial
diseases are required. The study demonstrates the potential of the PW analysis
in monitoring vascular abnormalities.
Keywords: Atherosclerosis, Electromechanical sensors,
Photoplethysmography, Peripheral arterial disease, Pulse wave measurements
1. Introduction
Atherosclerosis may be present as stiffening, stenosis or occlusion of the
arteries. Peripheral arterial disease (PAD) is a specific form of atherosclero-
sis affecting mainly the lower limbs. PAD may be asymptomatic, but often it
causes symptoms such as intermittent claudication, or conditions threatening
the vitality of the limb. These conditions may be critical limb ischemia with
rest pain and tissue defects and acute limb ischemia. PAD is also seen as a risk
factor of acute cardiovascular events such as a stroke or myocardial infarction.
PAD is treated commonly by means of percutaneous transluminal angioplasty
(PTA) in which the stenosed artery is dilated in a minimally invasive endovascu-
lar treatment procedure. According to the past experience, the PTA results in
the disruption of the atherosclerotic plaque and initiates the histological remod-
eling of the arterial wall [1]. In some cases, inward remodeling and a restenosis
occur, resulting in the worsening of the symptoms. The patency rates of the
PTA are reported to vary between 75 %–97 % and 60 %–84 % for one- and
two-year follow-up times, respectively[2]. Commonly, the patients are subjected
to a 1-month follow-up to ensure the technical success of the treatment. The
re-examination includes the measurement of the ankle-to-brachial pressure in-
dex (ABI). However, ABI has several limitations, such as varying sensitivity
and specificity from study-to-study [3] and challenges especially with the dia-
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betic and mediasclerotic patients [4, 5, 6]. As the ABI measurement has several
drawbacks, imaging methods such as magnetic resonance angiography (MRA)
or X-ray contrast-agent based angiography, could be alternatives. Still, MRA
has high costs and X-ray angiography causes exposure to radiation. Systolic toe
pressures or toe-to-brachial pressure index (TBI) have also been suggested as an
alternative to ABI especially to diabetic patients, but also they have problems
with the reliability [6]. Many studies have suggested pulse wave (PW) measure-
ment and analysis for finding vascular abnormalities or abnormal vascular aging
[7, 8, 9, 10, 11, 12].
Earlier, we have studied the repeatability of the PW-measurements and if
there exist differences in the PW-morphologies between different-aged subjects
as well as between healthy subjects and atherosclerotic patients in the signals
recorded from various locations [11]. The experimental set-up of these studies
limits the results only to provide information on the overall condition of the
arterial tree without data on the effect of the stenosis itself. In this study, we
test the suitability of the PW measurement and analysis for the monitoring of a
superficial femoral artery (SFA) stenosis treated by PTA and provide informa-
tion on the effects of PTA on PW. We hypothesize that PTA causes quantitative
changes in the observed PW and that the effect of the treatment is observed im-
mediately after the treatment and more clearly in the follow-up visit within one
month due to remodeling initiated by the PTA. We also test if the studied PW-
analysis methods are suitable for diagnostic use, e.g. if there are pre-treatment
differences in the PW-features between the treated and non-treated lower limb.
A benefit of the PW measurement compared with the static ABI measurement
or angiographs is that it provides information also on the vascular dynamics.
2. Materials and methods
2.1. Measurement hardware and sensor placement
The measurement data was collected in supine position by using electret
sensors made of electromechanical film (EMFi) (Emfit S-series, Emfit Ltd, Fin-
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land) and PPG probes (S0010A, Shenzhen Med-link, China) connected to a
wireless body sensor network (WBSN) [13]. The sampling frequency was 250
Hz for the EMFi signals and 500 Hz for the PPG signals. The EMFi signals were
interpolated to have a sampling frequency of 500 Hz in further signal processing.
EMFi-sensors, which are sensitive only to dynamic but not to static loading,
were placed at the wrist on the top of the radial artery, and both ankles on the
top of the posterior tibial artery in order to record dynamic pressure PW signals,
i.e. a signal proportional to the varying AC-component or pulse pressure of the
blood pressure signal.
Transmission mode PPG probes having an excitation wavelength of 905 nm
were placed on index finger and both 2nd toes for recording blood volume PW
signals. In addition to the PW-signal, bipolar ECG (electrocardiogram) was
also measured by using conventional silver-silver chloride (Ag/Cl) electrodes
placed under the clavicles and an ECG-device compatible with the WBSN [13].
The ECG was utilized in the extraction of the PWs.
The measurements were conducted during the pre-, peri-, and post-treatment
phases of the PTA and during the follow-up visit after one month (median 33
days, inter-quartile range (IQR) 30–36 days). For peri-procedural data collec-
tion, the sensors were placed before the normal preparation of the PTA and were
removed within 5–10 minutes after the PTA. The sensor placement was similar
in the follow-up visit, but the duration of the measurement was 5 minutes and
was done before the ABI and toe pressure measurements.
The ankle PW-signals were excluded from the analysis since they were dis-
turbed heavily especially during the treatment mainly for two reasons: First,
the PAD patients commonly have extremely low-amplitude pressure PW-signals
and therefore the measurement is also very sensitive to the correct positioning
of the sensors. Second, the operating table in the PTA room was narrow, which
often forced patient’s lower limbs in such position that the structures containing
EMFi sensors touched each other or the operating table, and this caused major
artifacts to the signal.
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2.2. Reference values
The ABI is defined as a ratio of the systolic blood pressures measured by a
cuff from an arm and an ankle, i.e. ABI = Pankle/Pbrachial. ABI was computed
by dividing the highest ankle pressure (either ADP (arteria dorsalis pedis) or
ATP (arteria tibialis posterior)) by the highest arm pressure (left or right).
Toe pressures refer to the systolic pressures measured from the hallux. Both
reference values were collected by using an automated measurement device,
Falcon Pro (Viasonix, Israel). Pre-treatment (visit at polyclinics before the
PTA) and follow-up visit ABI and toe pressure measurements were conducted
as a part of normal clinical practice and used as the reference values in the
study.
2.3. Study subjects
The inclusion criteria of the study were the abnormal ABI reading, i.e.
ABI< 0.9 or ABI> 1.3, relevant symptoms, stenosis in SFA based on mag-
netic resonance imaging angiography and a patient considered as a candidate
for the PTA of the SFA. A pacemaker and a possible risk that the study in-
terferes the patient’s treatment process were considered as exclusion criteria.
Altogether 27 volunteer patients undergoing PTA of the SFA were recruited
for the study. Three of them were excluded for the following reasons: research
personnel unavailable, a patient was found to be unsuitable for PTA during
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Ankles:
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PPG
ECG
Figure 1: Sensor placement.
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the imaging and extremely low peripheral perfusion. 14 left and 12 right lower
limbs were treated, including two patients with both lower limbs treated. More
detailed data on the study subjects is shown in Table 1. A clear majority of the
included patients met the criterion ABI< 0.9 — only one of the patients had
pre-treatment ABI higher than 1.3. 15 non-treated lower limbs out of 22 lower
limbs (68 %) also had the ABI value outside the normal range of 0.9 <ABI< 1.3
at least in one of the pre-treatment or follow-up visit ABI measurements.
Table 1: Data describing the study subject population including clinical reference values, ABI
and toe pressure.
Parameter Median (IQR)
Mass (kg) 75.5 (67.0...93.0)
Height (cm) 170.0 (165.5...176.0)
BMI (kg/m2) 26.7 (24.4...30.0)
Age (years) 71.5 (67.5...76.0)
Treated lower limbs: 26
ABI, pre-treatment 0.61 (0.50...0.75) *
ABI, follow-up 0.96 (0.82...1.04) #
Toe pressure, pre-treatment (mmHg) 59.0 (42.0...86.0) **
Toe pressure, follow-up (mmHg) 94.5 (76.0...122.0) ##
Non-treated lower limbs: 22
ABI, pre-treatment 0.88 (0.75...1.02) *
ABI, follow-up 0.94 (0.72...1.08) #
Toe pressure, pre-treatment (mmHg) 75.5 (53.0...117.5) **
Toe pressure, follow-up (mmHg) 99.5 (66.0...122.0) ##
Parameter Number (%)
Males 16 (66.7 %)
Diabetes 11 (45.8 %)
Dyslipidemia 22 (91.7 %)
Rheumatoid arthritis 3 (12.5 %)
Current smoker 2 (8.3 %)
Ex-smoker 11 (45.8 %)
p-values for the pre-treatment ABI and toe pressure values between treated and non-treated limb:
∗: p < 0.001, **: p < 0.1, # and ##: not signigicant
BMI: Body-mass index; IQR: inter-quartile range.
2.4. Ethics and patient safety
The study was approved by the local ethical review board of the hospital
district (R15107), the Finnish National Supervisory Authority of Health and
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Welfare (Valvira, ID 309) and the technical department of the hospital. The
study was registered to a public clinical trials register (ClinicalTrials.gov ID:
NCT02725307). Written informed consents were obtained from the volunteer
patients participating in the study.
2.5. Pulse wave analysis
The PW-extraction was implemented first by finding R-peaks from the ECG
by an algorithm proposed in [14]. After that, local mimima following each
detected R-peak were extracted from the pulse wave signals. The pulse wave
signal between the successive local minima was considered as a PW candidate.
The validity of the PW candidates was tested by using adaptive thresholds.
A PW candidate was rejected if 1) the slope of the rising edge of the PW
candidate was not positive for 50 ms or if its average slope was less than 30% of
the maximum slope; 2) the difference of the minimum and maximum value of
the PW-candidate was outside certain thresholds; or 3) amplitude-normalized
PW candidate was outside predefined limits for at least 20% of its duration.
In pre-processing, the signals were filtered with a Savitzky-Golay smoothing
filter having a window length of 91 samples (182 ms) and a polynomial order of
2. In addition, the signals were forward-backward filtered with a finite impulse
response low-pass filter having a cutoff frequency of 10 Hz, transition band of
10–12 Hz, pass band ripple of 0.05 dB, and stop band attenuation of 100 dB
[15], as implemented in [16, 11]. After pre-processing and feature extraction, the
PWs were characterized by computing altogether 10 different PW-parameters.
2.5.1. PW-curve derived features
The features extracted from the PWs were originally proposed either for
radial pressure PW-analysis or digital volume (PPG) PW-analysis as e.g. in
[17, 18]. In earlier studies [16, 11], we extracted similar features also from
the lower limb PWs by using algorithms that were originally implemented for
upper limb PWs and proposed in [15, 19]. In this study, we analyzed how these
features, extracted from lower limb PWs, are changed as a result of the PTA of
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the SFA. Numerous studies have presented results that the morphology of both
pressure and volume pulse wave depends on the status of the vasculature. The
resistance and compliance of the arterial pathway affects the wave propagation
and reflection [9], but the exact physiological origin and significance of the
differences requires further studies especially in case of lower limbs.
Different parameters were computed based on the amplitudes and time dif-
ferences between the systolic and diastolic waves as in [11] and illustrated in
Fig. 2. When finding the fiducial points for P1, P2, and B, the incisura or
dicrotic notch dividing the individual PW into systolic and diastolic parts was
found as the last zero-crossing from negative to positive of the 1st derivative f ′
of the PW in the search window limited by a point 80 ms after the maximum
of the PW and a point which corresponds to 65% from the total length of the
PW. In case of the absence of this zero-crossing, the location of incisura was
detected at the location of the highest peak of the 2nd derivative f ′′ found from
the same interval [16]. Based on these features, the following parameters were
computed:
• R1 as a ratio of the amplitude of diastolic wave B and the systolic max-
imum (the maximum of P1 and P2 in Fig. 2), i.e. R1 = B/max(P1, P2),
named as reflection index for index-finger PPG in [18],
• R2 as a ratio of the amplitude of diastolic wave B and early systolic wave
P1, i.e. R2 = B/P1
• R3 as a ratio of the amplitude of diastolic wave B and late systolic wave
P2, i.e. R3 = B/P2
• R4 as a ratio of the amplitude of late (P2) and early (P1) systolic wave, i.e.
R4 = P2/P1, named as peripheral augmentation index for wrist pressure
pulses e.g. in [17],
• T1 as a time difference between systolic maximum (max(P1, P2)) and the
peak of the diastolic wave (B)
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Figure 2: Examples of the PWs, locations of fiducial points and time intervals, and values of
the derived parameters from one test subject before and after the PTA as well as during the
follow-up visit. Also T1–T3 are illustrated in the PW shown in the right upper corner. T1 and
T3 are equal in all these examples, since P2 is the maximum of the PW in all the examples.
Each pair of the PWs from treated and non-treated lower limb are recorded concomitantly.
• T2 as a time difference between early systolic peak (P1) and the diastolic
peak (B)
• T3 as a time difference between late systolic peak (P2) and the diastolic
peak (B)
The peaks of early and late systolic waves P1 (Fig. 2) and P2 as well as diastolic
wave B were found based on the method described in [16, 19]. These peaks are
often overlapped in the PWs recorded from atherosclerotic patients, but they
are more obvious in radial or carotid PWs and in lower limb PWs recorded from
healthy subjects [16, 11]. For these reasons, the fiducial points were found by
implementing 5th-order derivative analysis as in [16, 19].
After finding the boundary between the systolic and diastolic parts, the
following procedure was implemented for finding P1 and P2 [16, 19]: If the sign
of the 5th derivative f (5) at the point corresponding to the systolic maximum
of the PW was
1. positive, this point was considered as a point for the late systolic peak P2
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and the last zero-crossing of 4th derivative f (4) from positive to negative
before P2 as early systolic peak P1.
2. negative, this point was considered as a point for the early systolic peak
P1 and the first zero-crossing of f
(4) from negative to positive after P1 as
a late systolic peak P2.
In order to find the diastolic wave B, the zero-crossing of 1st derivative f ′
from positive to negative in the diastolic part of the PW was selected as the
location of the diastolic peak. If such diastolic zero-crossing of f ′ was missing,
the location for the diastolic peak was defined as the first zero-crossing of 2nd
derivative f ′′ from positive to negative in the diastolic part of the PW [16].
Aging index (AGI) based on the 2nd derivative of an individual toe-PPG
PW signal was computed as AGI = (b − c − d − e)/a in which a is the peak
amplitude of the 2nd derivative of the PW and b, c, d, and e are the amplitudes
of the following local extremities of the 2nd derivate [18].
The amplitude ratios R1–R4 and AGI derived for the lower limb PPG are
observed to increase with age and atherosclerotic changes and time delays T1–T3
to decrease with age and atherosclerotic changes in [11, 16].
2.5.2. Area ratios
Two different ratios of areas under amplitude-normalized PWs recorded from
different locations were extracted as
• Awt = Awrist/Atoe
• Aft = Afinger/Atoe
in which Awrist, Atoe and Afinger refer to area under wrist, toe, and finger PWs,
respectively. These areas were computed by using trapezoidal numerical inte-
gration.
2.6. Statistical methods
The distributions of the values of the PW-features found for the treated and
non-treated lower limb were compared by implementing non-parametric two-
10
tailed Mann-Whitney U-tests because of relatively small sample sizes and non-
symmetric distributions. The pair-wise differences between the values before
and after the PTA as well as in the follow-up visit were compared by imple-
menting two-tailed non-parametric sign tests for the same reasons as with the
Mann-Whitney U-tests.
Also the peri-procedural changes in the values of the PW-features caused
by the inserted endovascular instrumentation were analyzed by means of sign
tests in two cases: 1) before any endovascular preparation vs. all the necessary
equipment inserted to the SFA, and 2) immediately after the balloon angioplasty
or a possible stent installation vs. all the endovascular instruments removed.
The non-parametric methods instead of parametric tests were selected because
of the relatively small sample sizes and skewness of the distributions of the part
of the parameters.
Bland-Altman (BA) plot analysis was implemented for both PW-derived
indices as well as reference values in order to see if there are differences between
the groups of treated and non-treated lower limbs. In the BA-plot, the difference
between two measurements (pfollow−up − pbefore) is plotted against the average
of two measurements (1/2 · (pbefore + pfollow−up)) in which pbefore is the pre-
treatment value and pfollow−up is the value in the follow-up visit.
In order to study if the values of the PW-features and reference values (ABI
and toe pressure) change in the same direction as a result of treatment, fixed-
marginal multirater κ-analysis[20] was performed for the values found for the
treated lower limbs. If the value develops in a healthier direction, i.e. the
waveform changes towards the values measured for healthy volunteers in [11]
as a result of the treatment, that value was categorized as positive change, and
if the value develops towards worse condition, that value was categorized as
negative change. The κ-analysis is performed between PW-derived indices and
ABI as well as between PW-derived indices and toe pressures. An increase in
ABI and toe pressure value is considered as a positive change towards healthier
condition.
Multiple linear regression models are constructed for finding if the change
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in the values is explained by the treatment and remodeling or other changing
factors.
2.7. Pre-treatment repeatability
Pre-treatment beat-to-beat repetability was studied by means of the intra-
class correlation coefficient (ICC) based on the one-way random effect model
[21, 22] and coefficient of variation (CV). ICC was used to estimate the repeata-
bility of the series of measurements and it was defined as a ratio of between-
subject variance and the sum of between-subject and within-subject variances
and estimated as
ICC =
MSbs −MSws
MSbs + (k − 1)MSws (1)
in which MSbs is between-subject mean squares, MSws is within-subject mean
squares from ANOVA (analysis of variance) table and k is the number of ob-
servations per subject which computed as in [22] in case of unequal number of
observation per test subject as in this case. CV is defined as a ratio between
sample standard deviation s and mean m as CV=s/m.
3. Results
The amplitude ratio R4 and AGI did not reveal any statistically significant
differences between any of the studied situations or between treated and non-
treated limbs, so more detailed results related to them are not reported.
3.1. Distributions of the PW-parameters between pre-treatment state and follow-
up visit
The distributions of the values of the PW-features before the treatment and
at the follow-up visit are presented in Table 2 in terms of median and IQR for
both treated and non-treated lower limbs. Generally, there were no differences at
group level in the pre-treatment values between treated and non-treated limbs.
The area ratio Aft was an exception (p < 0.05) suggesting only weak difference
between the pre-treatment condition of treated and non-treated limb. If the
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Table 2: Distributions (median and IQR) of the values of the PW-features for treated and
non-treated limb for both pre-treatment condition and a situation at the follow-up visit.
Pre-treatment Follow-up visit
Para- Treated limb Non-treated limb Treated limb Non-treated limb
meter Median (IQR) Median (IQR) Median (IQR) Median (IQR)
R1 0.52 (0.45...0.57) 0.47 (0.32...0.53) 0.34 (0.27...0.44) 0.38 (0.28...0.53)
R2 0.56 (0.48...0.63) 0.52 (0.34...0.62) 0.37 (0.29...0.50) 0.40 (0.29...0.54)
R3 0.56 (0.50...0.61) 0.51 (0.33...0.60) 0.40 (0.27...0.49) 0.43 (0.28...0.58)
T1 0.27 (0.23...0.36) 0.30 (0.24...0.35) 0.34 (0.31...0.39) 0.31 (0.26...0.35)
T2 0.31 (0.28...0.40) 0.34 (0.28...0.38) 0.36 (0.34...0.43) 0.35 (0.30...0.42)
T3 0.22 (0.19...0.30) 0.25 (0.21...0.32) 0.30 (0.25...0.36) 0.29 (0.23...0.35)
Awt 0.81 (0.78...0.89) 0.86 (0.82...0.94) 0.90 (0.84...0.97) 0.87 (0.80...0.99)
Aft 0.91 (0.87...0.98)• 0.99 (0.91...1.07)• 0.97 (0.90...1.11) 0.97 (0.86...1.08)
•: p < 0.05
pre-treatment reference values are studied, ABI provides statistically significant
differences between treated and non-treated lower limb whereas the sample size
is slightly too small for finding significant differences with toe pressures (Table
1). Neither the PW-derived parameters (Table 2) nor the reference values (Table
1) show differences between the distributions of treated and non-treated lower
limbs at the follow-up visit.
3.2. Changes during the PTA
Clear changes during the PTA were observed only when the PTA-balloon
was filled: at those points, the amplitude of the PW decreased at least 50 %
except for one test subject. According to the implemented statistical tests, the
inserted endovascular instrumentation does not otherwise cause changes to the
values of studied PW-parameters.
3.3. Immediate pre- and post-treatment changes
The immediate changes caused by the treatment are relatively small (Figs.
3a–c) compared with changes found in the follow-up visit (Figs. 3h–j). Statis-
tically significant differences for these immediate changes in the values of the
PW-features of the treated limbs were found only for R2, T2, T3, and Aft even
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Figure 3: Distributions for the changes of different values: in each pair of boxplots, the black-
bordered left-hand side box is for the treated lower limbs and the gray-bordered right-hand
side box is for the non-treated lower limbs. In the vertical axis, pafter refers to the post-
treatment values immediately after the treatment, pbefore to the values immediately before
the treatment and pfollow−up to the values in the follow-up visit.
though the trend of other values is also in the healthier direction as described
in [11].
The changes found for the values of the PW-features of the non-treated limb
do not show any statistically significant differences between pre-treatment and
post-treatment conditions. With most of the parameters (R1–R3, T1–T3, and
Aft) the distribution of the immediate changes in the values of the treated limbs
differ significantly from changes found for the non-treated limbs (Figs. 3a–c).
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3.4. Changes in the follow-up visit
The changes in amplitude ratios R1–R3, time differences T1–T3 and area
ratio Awt for the treated lower limb indicate statistically significant differences
between the follow-up visit and the post-treatment situation as well as between
follow-up visit and pre-treatment situation (Figs. 3e–j). With these parameters,
the distributions of the changes found for the treated and non-treated limb from
differ each other statistically, and this is also observed by a visual inspection: the
changes in the non-treated limb are clearly more zero-centered than the changes
in the treated limb in which the trend is in the healthier direction reported in
[16]. These trends in the amplitude ratios (Ri) and time differences (Ti) are
also seen in the examples of the PWs recorded in different situations shown in
Fig. 2.
3.5. Comparison with ABI and toe pressures
The BA-plots are shown in Fig. 4 for the pre-treatment situation and the
follow-up visit for the PW-derived parameters as well as for the reference values
ABI and toe pressures. The 95% limits of agreement were not drawn for the
treated limbs since the change in the measurand as a result of the PTA is
assumed. In the ideal case and after successful PTA treatment, the BA-plot
should indicate no difference or deviation in the readings of the non-treated
limb and a consistent difference (bias) towards healthier condition in the treated
limb. With the PW-parameters, the deviations are high for both treated and
non-treated limbs. However, this is the case also for the reference values: For
treated limbs, bias and 95% limits of agreement of 0.27± 0.47 and (28.9± 64.5)
mmHg were found for the ABI and toe pressure, respectively. Even for the non-
treated limb, bias and 95% limits of agreement of 0.06 ± 0.37 and (0.2 ± 82.0)
mmHg were found for ABI and toe pressure, respectively.
In addition to BA-plots, the free-marginal multirater κ-values between PW-
derived parameters and the reference values, ABI and toe pressures, of the
treated lower limb are shown in Table 3. All the PW-derived parameters which
showed statistically significant differences between the pre-treatment situation
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and follow-up visit have at least moderate acceptance with the ABI, and the
κ-values between ABI and R1, R3, T1 and T2 parameters are even higher than
the κ-value between ABI and toe pressure (0.75). All κ-values between the ABI
and PW-derived parameters are higher than corresponding values between toe
pressures and PW-derived parameters.
Table 3: Free-marginal multirater κ values for the changes between different values and ABI
and toe pressure.
Parameter ABI Toe pressure
R1 0.82 0.62
R2 0.73 0.52
R3 0.91 0.71
T1 0.73 0.62
T2 0.82 0.71
T3 0.82 0.71
Awt 0.52 0.30
Aft 0.55 0.52
Toe pressure 0.75
3.6. Multiple linear regression
The results of multiple linear regression analysis for the changes between
pre-treatment situation and follow-up visit are shown in Table 4. According to
the results, the changes are dependent on the treatment of the SFA but not on
the RR-interval except T2. Surprizingly the toe pressures are less dependent on
the treatment of the SFA than PW-derived indices and ABI.
3.7. Pre-treatment repeatability
Both ICC and CV are shown in Table 5 for beat-to-beat data in pre-treatment
situation. ICCs close to 0.9 or higher and median CVs less or equal than 2%
were observed. Both indicators show good repeatability and are inline with the
earlier study [11].
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Figure 4: Bland-Altman plots for the pre-treatment values and the values found in the follow-
up visit for each PW-parameter and the reference values ABI and toe pressure. The normal
range for ABI is also shown in black vertical dashed lines in panel i).
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Table 4: Multiple linear regression coefficients and significance levels. The marker after pa-
rameter name refers to p-value of the F-statistics vs. constant model.
Coefficients
Parameter Intercept ∆RR SFA PTA
R1◦ -0.047 -0.164 -0.116•
R2• -0.058 -0.257 -0.141•
R3• -0.041 -0.134 -0.133/
T1• 0.013 -0.056 0.054/
T2/ 0.010 -0.235• 0.047•
T3◦ 0.011 -0.129 0.052•
Awt• 0.005 0.047 0.086/
Aft• -0.004 0.123 0.108/
ABI/ -0.053 0.490 -0.210/
Toe pressure -4.731 19.928 -20.727*
∆RR: change in RR-interval
∗: p < 0.10, ◦: p < 0.05, •: p < 0.025, /: p < 0.01
Table 5: Intra-class correlations (ICC) and coefficients of variation (CV) for pre-treatment
measurement.
Parameter ICC (95% confidence limit) Median CV (1st...3rd quartile) (%)
R1 0.96 (0.93–0.97) 0.6 (0.4...3.0)
R2 0.96 (0.93–0.97) 0.5 (0.3...3.0)
R3 0.96 (0.94–0.97) 0.6 (0.4...2.9)
T1 0.89 (0.84–0.93) 1.5 (0.9...2.7)
T2 0.89 (0.83–0.92) 1.5 (0.8...3.5)
T3 0.91 (0.87–0.94) 2.0 (1.2...4.0)
Awt 0.96 (0.94–0.97) 1.9 (1.4...3.2)
Aft 0.97 (0.96–0.98) 1.3 (1.0...1.8)
4. Discussion
The presented results suggest that PTA caused significant changes in the fea-
tures extracted from the PWs. The majority (R1–R3, T1–T3, Awt, and Aft) of
the studied parameters showed statistically significant differences between pre-
treatment condition and a situation at the follow-up visit. Only R2, T2–T3, and
Aft showed differences between the pre-treatment and immediate post-treatment
values, but other PW-derived parameters still had trends towards healthier con-
dition. The PW-measurement is able to find some immediate changes, but the
results suggest that the remodeling of the plaque and arterial wall within the
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follow-up period makes the changes more visible. Therefore, the behaviour of
the post-treatment PW-parameters is similar to the post-treatment ABI as pro-
posed in [23] and especially if the pre-treatment ABI is less than 0.80 [24].
According to the results, the endovascular instrumentation inserted into SFA
does not affect the values of the peri-procedural PW-parameters. The indepen-
dence of the PW-parameters on the insertion of the endovascular instruments
could allow to monitor changes in PW morphology caused by the PTA in real
time, even though the immediate changes could be small.
4.1. PW-analysis and changes caused by PAD
To the extent of our knowledge, the presented study is the first study which
compares the values of lower-limb PW-derived parameters between the pre- and
post-treatment situations of the PTA of the SFA. However, the results are sup-
ported by other studies concentrating on the diagnosis of the PAD: Yokoyama
et al. [25] have reported an increase in PW velocity in diabetic patients due
to arterial stiffness, but decrease in the PW velocity in a lower limb having
PAD symptoms likely due to stenoses which decrease the blood pressure and
thus the PW velocity in the diseased lower limb. After the successful PTA,
the PW velocity increased indicating the changes in the lower limb vasculature.
Similar kind of results were found in this study: the values of the PW-derived
parameters change in the healthier direction as reported earlier in [11].
The PW-analysis can also reveal the beneficial wide-scale systemic remote ef-
fects of the PTA: Jacomella et al. [12] reported changes towards better condition
within 3-month follow-up period of the PTA of the SFA in a carotid artery aug-
mentation index based on a radial artery applanation tonometry. In the present
study, the medians of the distributions of R1–R3 in non-treated limbs (Table
2) shifted towards healthier values observed in [11] during the 1-month follow-
up period even though the patient-wise differences between pre-treatment and
follow-up visit situations were close to zero (Figs. 3h–j). However, the changes
in the IQRs were not as dramatic in Table 2. We assume that a successful PTA
restores physical activity, such as walking, also improving the condition of the
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contralateral lower limb and resulting in increased perfusion in the lower limbs.
Similar changes were also observed in the clinical references values (Table 1)
and Figs. 3d and 3k) which supports the assumption. The area ratios Awt
and Aft as well as time intervals T1–T3 behave differently: their distributions at
pre-PTA and follow-up visit situations did not differ from each other in case of
non-operated lower limbs (Table 2), indicating weaker dependence on positive
systemic remote effects. Further studies should confirm these assumptions.
There are also studies [7, 8, 9, 10] reporting bilateral differences between the
lower limbs with and without PAD. Erts et al. [10] have reported time differences
in the foot points (the beginnings of the PW) between the lower limb with and
without the PAD. Allen et al. [7, 8, 9] have found bilateral differences between
toe-PPG signals in unilateral PAD patients. A comparison between different
time delays between the peak or foot points of the PWs from different locations
and between the patients and control subjects is also in our future interests.
4.2. Limitations of the method
In previous study[11], statistically significant differences were found for the
study groups consisting of patients having atherosclerotic changes and same-
aged healthy control subjects. The experimental setup in the previous study
[11] was different than in this study in which the lower limbs that underwent
SFA of the PTA were compared with the lower limbs without the PTA. The
results of the present study do not show significant bilateral differences between
the treated limb and the non-treatment limb if the pre-treatment values of the
PW-derived parameters are studied. This possibly limits the diagnostic use of
the studied PW-analysis methods.
Possible reason is that 68% of non-treated lower limbs provided abnormal
ABI reading at least in one of the two measurements. If a patient has the symp-
toms of PAD in one limb, there is a high likelihood of atherosclerotic changes
also contralaterally and elsewhere in the vasculature. The studied PW-derived
parameters may also be sensitive to all kinds of degenerative atherosclerotic
changes including the stiffening of the large arteries such as the aorta, not only
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the stenoses and occlusions which are the typical lesions of the PAD. Still, de-
pending on the method, either bilateral comparison or unilateral measurement
can provide the better performance, even though the differences are small as in
[8, 9].
If the obvious sources of error in the PPG-measurement, such as incorrectly
placed PPG-probe and motion artefacts, are excluded, there are a few method-
ological limitations. Poor peripheral perfusion decreases the amplitude of the
PPG-signal and may prevent the proposed analysis. The low-amplitude PPG-
signal can be a marker of PAD, but can also be caused by vasoconstriction
as the result of low temperature. The body position affects the shape of the
PPG-signal and is a topic of further studies. However, in the present study,
all the measurements were conducted in supine position and limbs extented.
Light from the environment can disturb the PPG-signals, but in our measure-
ments, regular 50 Hz and 100 Hz frequency components caused by the mains
and the fluorescent lights were the most significant sources of disturbance and
were eliminated by the filtering.
Despite the limitations discussed, the results suggest that PTA has an ef-
fect on most of the features extracted and evaluated in the present study. The
analysis of the PW-features may provide additional information in finding the
early signs of PAD or in monitoring the treatment during the follow-up period
especially in the cases in which the conventional methods, ABI and toe pres-
sure measurements, provide in unreliable or conflicting results. A part of the
features combined with other health data may be utilized also as the inputs of
multivariate analysis methods or machine learning which would be a topic of
further studies.
5. Conclusions
Statistically significant differences were found in the values of the PW-
derived features between pre-treatment and immediate post-treatment condi-
tion. Stronger differences in the treated lower limb were found between the
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pre-treatment values and the post-treatment conditions after a 1-month follow-
up period. In both cases, the changes in the values of the treated limb differed
significantly from the corresponding changes found for the non-treated lower
limb. In case of the non-treated lower limbs, the variations of the differences
between different measurement events were relatively high but without a consis-
tent trend towards healthier or worse condition. The endovascular instrumen-
tation inserted into SFA did not affect the PW-parameters. The study was not
able to show statistically significant differences in the pre-treatment values of
the PW-derived parameters between the treated and non-treated lower limbs.
This is possibly explained by the study sample: 68 % of the non-treated limbs
produced an abnormal ABI-reading at least for one of the two measurements.
This indicates that many patients had subclinical atherosclerotic changes also in
the other lower limb. Prior to the real utilization of the measurement method,
further comparison of the healthy subjects and PAD-patients and having stan-
dardized measurement conditions should confirm the findings.
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